BioAtla (BCAB) Accumulated Expenses (2020 - 2025)
BioAtla (BCAB) posted quarterly Accumulated Expenses of $37000.0 for Q4 2025, down 98.64% year-over-year from $2.7 million in Q4 2024, and down 98.47% quarter-over-quarter from $2.4 million in Q3 2025.
BioAtla (BCAB) Accumulated Expenses (2020 - 2025) Analysis & Trends
BioAtla's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $37000.0 for Q4 2025.
- In Q4 2025, Accumulated Expenses fell 98.64% year-over-year to $37000.0; the TTM figure through Dec 2025 stood at $37000.0 (down 98.64% YoY), while the FY2025 annual figure was $37000.0, down 98.64% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $37000.0, down from $2.4 million in the prior quarter.
- The five-year high for Accumulated Expenses was $3.8 million in Q4 2023, with the low at $37000.0 in Q4 2025.
- The 5-year median for Accumulated Expenses is $2.2 million (2021), against an average of $2.1 million.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses advanced 29.2% in 2022, then sank 98.64% in 2025.
- BioAtla's Accumulated Expenses stood at $2.7 million in 2021, then gained by 29.2% to $3.5 million in 2022, then grew by 9.82% to $3.8 million in 2023, then dropped by 28.07% to $2.7 million in 2024, then tumbled by 98.64% to $37000.0 in 2025.
- Business Quant data shows BCAB's Accumulated Expenses at $37000.0 in Q4 2025, $2.4 million in Q3 2025, and $1.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BioAtla | 5.41 Mn | 5.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 2.73 Mn |
| Sep 30, 2024 | 3.06 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 3.79 Mn |
| Sep 30, 2023 | 2.97 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 3.45 Mn |
| Sep 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 1.83 Mn |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 2.67 Mn |
| Sep 30, 2021 | 3.01 Mn |
| Jun 30, 2021 | 2.24 Mn |
| Mar 31, 2021 | 833,000.00 |